UK-NAP Roundtable 2024
To support the ongoing work of the AMI One Health Advisory Group, the committee convened a roundtable bringing together experts from across the applied microbiology community. The session formed part of AMI’s broader engagement with stakeholders interested in contributing to Advisory Group activities or learning more about their work.
In May 2022, the UK government published an addendum outlining updates to the national antimicrobial resistance (AMR) action plan. These revisions were introduced to ensure that commitments were more specific, measurable, achievable, realistic, and time-bound. They also incorporated lessons learned from the COVID-19 pandemic, reflected progress made in reducing antibiotic prescribing in food-producing animals, and aligned with the development of new sector-specific targets.
The roundtable discussion aimed to bring together representatives from industry, academia, science policy, and other key stakeholder groups to review these updates. Participants were invited to contribute their expertise toward shaping a practical roadmap to complement the addendum and support delivery of the UK’s five-year AMR action plan.
Agenda Overview
The event followed a structured agenda, beginning with an introduction at 14:00. This was followed by a session on human health at 14:15, which explored key issues and perspectives related to antimicrobial resistance in clinical and public health settings.
At 15:00, the focus shifted to animal health, highlighting challenges and progress within veterinary and agricultural sectors. A coffee break was held at 15:30 in the Main Atrium, providing attendees with an opportunity for informal networking.
Proceedings resumed at 15:45 with a session on collaboration and research, emphasising cross-sector partnerships and future priorities. The event concluded with final remarks and a summary of key discussions at 16:45.
Attendees
The roundtable included the following participants:
- Claire Anderson, President, Royal Pharmaceutical Society
- Jessica Blair, Senior Lecturer, Institute of Microbiology and Infection
- Sarah Chadwick, AMR Programme Manager, West Yorkshire Health and Care Partnership NHS
- Elaine Cloutman-Green, Consultant Clinical Scientist and Deputy Director of Infection Prevention and Control, Great Ormond Street Hospital
- Michael Corley, Head of Policy & Public Affairs, British Society for Antimicrobial Chemotherapy (BSAC)
- Nina Garrett, R&D Director, Abingdon Health
- Meenakshi Gautham, Head of Economic, Social and Political Sciences, AMR Centre, LSHTM
- Kitty Healey, Head of Antimicrobial Resistance, Veterinary Medicines Directorate, Defra
- Claire Hill, UK Senior Account Executive, UgenTec
- Catherine McLaughlin, Chief Adviser (Animal Health & Welfare), NFU and Chair of RUMA
- Alan McNally, Professor in Microbial Evolutionary Genomics and Institute Director, Institute of Microbiology and Infection
- David Pearce, Professor of Environmental Microbiology, Northumbria University
- Jonathan Pearce, CEO, Antibiotic Research UK
- Adam Roberts, Senior Lecturer, Liverpool School of Tropical Medicine
Event Details
The event took place in London on 29 November 2022, from 14:00 to 17:00, at The Smith Centre, Science Museum.